Higher incidence of zinc and nickel hypersensitivity in patients with irritable bowel syndrome. 2019

Yasunari Kageyama, and Koichi Aida, and Kimihiko Kawauchi, and Masafumi Morimoto, and Tetsu Akiyama, and Tsutomu Nakamura
Takanawa Clinic, Tokyo, Japan.

The etiology of irritable bowel syndrome (IBS) remains elusive even though several genetic and environmental pathogenic factors have been reported. IBS is considered to be a functional disorder without any detectable lesions in the patient's bowel. However, many studies have demonstrated that a subset of IBS patients have low-grade inflammation and aberrant T-cell activation in their intestinal mucosa. To elucidate the immune mechanism underlying the mucosal inflammation in IBS, we focused on dental metal hypersensitivity, a T cell-mediated, delayed-type allergic reaction that causes oral contact mucositis and systemic cutaneous inflammation. We recruited 147 Japanese IBS patients and 22 healthy controls (HCs). The subjects underwent the in vitro lymphocyte stimulation test to quantify their sensitivity to zinc, gold, nickel, and palladium, the metals that have been commonly used in dentistry. A total of 56.5% of the IBS patients were hypersensitive to at least one metal species, whereas 31.8% of HC were hypersensitive to only a single metal species. The overall incidence of metal hypersensitivity was significantly higher for IBS patients than for HC. Furthermore, a significantly higher proportion of IBS patients were hypersensitive to zinc and/or nickel. The severity of the sensitivity to zinc and nickel was also significantly greater for IBS patients than for HC. There was no significant difference in the sensitization rates and the sensitivity among the IBS subtypes. This pilot study demonstrates that IBS patients have a significantly higher prevalence of hypersensitivity to zinc and nickel, suggesting the possible involvement of dental metal hypersensitivity in IBS pathogenesis in a subset of patients.

UI MeSH Term Description Entries
D006967 Hypersensitivity Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen. Allergy,Allergic Reaction,Allergic Reactions,Allergies,Hypersensitivities,Reaction, Allergic,Reactions, Allergic
D008297 Male Males
D009532 Nickel A trace element with the atomic symbol Ni, atomic number 28, and atomic weight 58.69. It is a cofactor of the enzyme UREASE.
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015032 Zinc A metallic element of atomic number 30 and atomic weight 65.38. It is a necessary trace element in the diet, forming an essential part of many enzymes, and playing an important role in protein synthesis and in cell division. Zinc deficiency is associated with ANEMIA, short stature, HYPOGONADISM, impaired WOUND HEALING, and geophagia. It is known by the symbol Zn.
D015994 Incidence The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time. Attack Rate,Cumulative Incidence,Incidence Proportion,Incidence Rate,Person-time Rate,Secondary Attack Rate,Attack Rate, Secondary,Attack Rates,Cumulative Incidences,Incidence Proportions,Incidence Rates,Incidence, Cumulative,Incidences,Person time Rate,Person-time Rates,Proportion, Incidence,Rate, Attack,Rate, Incidence,Rate, Person-time,Rate, Secondary Attack,Secondary Attack Rates
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D043183 Irritable Bowel Syndrome A disorder with chronic or recurrent colonic symptoms without a clearcut etiology. This condition is characterized by chronic or recurrent ABDOMINAL PAIN, bloating, MUCUS in FECES, and an erratic disturbance of DEFECATION. Colitis, Mucous,Colon, Irritable,Colitides, Mucous,Irritable Bowel Syndromes,Irritable Colon,Mucous Colitides,Mucous Colitis,Syndrome, Irritable Bowel,Syndromes, Irritable Bowel

Related Publications

Yasunari Kageyama, and Koichi Aida, and Kimihiko Kawauchi, and Masafumi Morimoto, and Tetsu Akiyama, and Tsutomu Nakamura
September 2023, Cureus,
Yasunari Kageyama, and Koichi Aida, and Kimihiko Kawauchi, and Masafumi Morimoto, and Tetsu Akiyama, and Tsutomu Nakamura
November 2010, Pain medicine (Malden, Mass.),
Yasunari Kageyama, and Koichi Aida, and Kimihiko Kawauchi, and Masafumi Morimoto, and Tetsu Akiyama, and Tsutomu Nakamura
January 2019, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
Yasunari Kageyama, and Koichi Aida, and Kimihiko Kawauchi, and Masafumi Morimoto, and Tetsu Akiyama, and Tsutomu Nakamura
December 2017, Neurogastroenterology and motility,
Yasunari Kageyama, and Koichi Aida, and Kimihiko Kawauchi, and Masafumi Morimoto, and Tetsu Akiyama, and Tsutomu Nakamura
August 2014, Neurogastroenterology and motility,
Yasunari Kageyama, and Koichi Aida, and Kimihiko Kawauchi, and Masafumi Morimoto, and Tetsu Akiyama, and Tsutomu Nakamura
April 2001, Alimentary pharmacology & therapeutics,
Yasunari Kageyama, and Koichi Aida, and Kimihiko Kawauchi, and Masafumi Morimoto, and Tetsu Akiyama, and Tsutomu Nakamura
September 1983, Lancet (London, England),
Yasunari Kageyama, and Koichi Aida, and Kimihiko Kawauchi, and Masafumi Morimoto, and Tetsu Akiyama, and Tsutomu Nakamura
April 2011, Journal of gastroenterology and hepatology,
Yasunari Kageyama, and Koichi Aida, and Kimihiko Kawauchi, and Masafumi Morimoto, and Tetsu Akiyama, and Tsutomu Nakamura
August 1983, Lancet (London, England),
Yasunari Kageyama, and Koichi Aida, and Kimihiko Kawauchi, and Masafumi Morimoto, and Tetsu Akiyama, and Tsutomu Nakamura
January 2001, Digestive diseases (Basel, Switzerland),
Copied contents to your clipboard!